SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the September 2025 quarter is pegged at Rs. 17571.50 millions, about 7.62% up against Rs. 16326.70 millions recorded during the year-ago period.Net profit stood at Rs. 4152.70  millions  compared to Rs. 3586.10 millions in the corresponding previous quarter,high by 15.80%.Operating profit surged to 5721.20 millions from the corresponding previous quarter of 4994.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 17571.50 16326.70 7.62 34955.00 31902.80 9.57 64091.50 58489.10 9.58
Other Income 699.50 604.80 15.66 1427.90 1278.10 11.72 2755.80 2482.70 11.00
PBIDT 5721.20 4994.40 14.55 10905.50 9577.80 13.86 19701.80 17013.70 15.80
Interest 75.50 25.00 202.00 133.70 52.50 154.67 114.30 124.50 -8.19
PBDT 5645.70 4969.40 13.61 10771.80 9525.30 13.09 19587.50 16889.20 15.98
Depreciation 186.40 175.10 6.45 381.20 358.80 6.24 718.00 711.70 0.89
PBT 5459.30 4794.30 13.87 10390.60 9166.50 13.35 18869.50 16177.50 16.64
TAX 1306.60 1208.20 8.14 2579.30 2300.30 12.13 4725.10 4165.30 13.44
Deferred Tax -10.00 -2.10 376.19 -15.00 -23.70 -36.71 27.20 10.70 154.21
PAT 4152.70 3586.10 15.80 7811.30 6866.20 13.76 14144.40 12012.20 17.75
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 32.56 30.59 6.44 31.20 30.02 3.92 30.74 29.09 5.68

Abbott India Share Price

25198.45 -224.05 (-0.88%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×